Aleksandras Gutmanas1, Paul D Adams2, Benjamin Bardiaux3, Helen M Berman4, David A Case4, Rasmus H Fogh5, Peter Güntert6, Pieter M S Hendrickx1, Torsten Herrmann7, Gerard J Kleywegt1, Naohiro Kobayashi8, Oliver F Lange9, John L Markley10, Gaetano T Montelione11, Michael Nilges3, Timothy J Ragan5, Charles D Schwieters12, Roberto Tejero13, Eldon L Ulrich10, Sameer Velankar1, Wim F Vranken14, Jonathan R Wedell10, John Westbrook4, David S Wishart15, Geerten W Vuister5. 1. Protein Data Bank in Europe, European Molecular Biology Laboratory, European Bioinformatics Institute, Cambridge, UK. 2. Physical Biosciences Division, Lawrence Berkeley Laboratory, Berkeley, California, USA. 3. 1] Département de Biologie Structurale et Chimie, Unité de Bioinformatique Structurale, Institut Pasteur, Paris, France. [2] Unité Mixte de Recherche 3528, Centre National de la Recherche Scientifique, Paris, France. 4. Department of Chemistry and Chemical Biology, Center for Integrative Proteomics Research, Rutgers, the State University of New Jersey, Piscataway, New Jersey, USA. 5. Department of Biochemistry, University of Leicester, Leicester, UK. 6. 1] Institute of Biophysical Chemistry, Frankfurt Institute of Advanced Studies, Goethe University Frankfurt am Main, Frankfurt am Main, Germany. [2] Graduate School of Science and Engineering, Tokyo Metropolitan University, Tokyo, Japan. [3] Physical Chemistry, Eidgenössische Technische Hochschule (ETH) Zürich, Zürich, Switzerland. 7. 1] Centre de Résonance Magnétique Nucléaire à Très Hauts Champs, Ecole Normale Supérieure de Lyon, Villeurbanne, France. [2] Institut des Sciences Analytiques, Unité Mixte de Recherche 5280, Centre National de la Recherche Scientifique, Villeurbanne, France. 8. Institute for Protein Research, Osaka University, Osaka, Japan. 9. Biomolecular NMR, Munich Center for Integrated Protein Science, Department Chemie, Technische Universität München, Garching, Germany. 10. Department of Biochemistry, University of Wisconsin-Madison, Madison, Wisconsin, USA. 11. 1] Center for Advanced Biotechnology and Medicine, Department of Molecular Biology and Biochemistry, Rutgers, the State University of New Jersey, Piscataway, New Jersey, USA. [2] Department of Biochemistry and Molecular Biology, Robert Wood Johnson Medical School, Rutgers, the State University of New Jersey, Piscataway, New Jersey, USA. 12. Division of Computational Bioscience, Center for Information Technology, National Institutes of Health, Bethesda, Maryland, USA. 13. Departamento de Quίmica Fίsica, Universidad de Valencia, Valencia, Spain. 14. 1] Structural Biology Research Centre, Vlaams Instituut voor Biotechnologie, Brussels, Belgium. [2] Structural Biology Brussels, Vrije Universiteit Brussel, Brussels, Belgium. [3] Interuniversity Institute of Bioinformatics in Brussels, Université Libre de Bruxelles-Vrije Universiteit Brussel, Brussels, Belgium. 15. 1] Department of Computing Science, University of Alberta, Edmonton, Alberta, Canada. [2] Department of Biological Sciences, University of Alberta, Edmonton, Alberta, Canada.
We present here a unified, easily adaptable, open-source NMR exchange format (NEF) for NMR restraints and associated data.Atomic-resolution, three-dimensional structures of macromolecules have been determined by NMR spectroscopy since the late 1980s. In 2013, the number of NMR-derived structures in the Protein Data Bank (PDB)[1] passed the milestone of 10,000 entries (Fig. 1), and they currently account for approximately 10% of the total number of structures in the PDB. To improve the quality and integrity of the archive, the Worldwide Protein Data Bank (wwPDB)[2], the consortium that manages the PDB archive, made the deposition of the underlying experimental data mandatory and established expert validation task forces (VTFs) to provide consensus recommendations for validating the structures and accompanying experimental data for entries determined by X-ray, NMR or cryo-EM techniques. The initial recommendations of the NMR VTF[3] have been implemented in a software pipeline that will be used to produce validation reports during structure deposition and annotation.
Figure 1
Growth in the number of NMR entries in the PDB archive.
NMR data and restraints are diverse in their nature: they are typically derived from various kinds of NMR experiments, and they may be interpreted differently by different software programs, even when the same spectral data are used as input. In addition, almost all NMR programs rely on a variety of formats, thus necessitating conversions when multiple programs are used in structure determination and analysis, with a concomitant risk of information loss or misinterpretation. Two software projects, NMR-STAR[4], developed at the Biological Magnetic Resonance Bank (BMRB)[5] with input from the NMR community, and the Collaborative Computational Project for NMR (CCPN)[6], provide systematic and comprehensive data models for storing and accessing NMR data. Unfortunately, neither of these two approaches has been widely adopted by the developers of popular software tools for NMR structure determination, refinement and validation, partly because both data models suffer from substantial and similar drawbacks: their data structures are large—more extensive and more complex than any single program would typically require—and they are not easily and independently adapted and extended for any specific program.NMR restraint data are currently deposited in a variety of software-specific formats that have to be curated by the BMRB into a common format for deposition in the NMR Restraints Grid (NRG)[7], thus enabling many useful applications. Unfortunately, efforts to develop universal restraint converters have been challenged because some restraint formats omit information required by other restraint formats[8], and full parsing of each software-specific format has proven to be impossible. The current situation hampers the proper archiving and use of bio-molecular NMR data, and prevents the routine inclusion of NMR restraint validation in the wwPDB NMR validation pipeline.For these reasons, the wwPDB partners, together with CCPN, organized a series of consultations and two workshops that included developers of key software packages used for NMR structure determination and refinement (Table 1), with the aim of attaining a unified approach to represent NMR restraints and associated data. Together, they agreed on and successfully implemented and tested an NMR data representation, denoted the NEF, and devised a governance structure for its maintenance and further development. Importantly, the different program developers committed to the ambitious goal of making their software capable of both reading and writing NEF-compliant files.
Table 1
Software packages implementing the NEF
Software package
Category
Principal investigator or representative
AMBER
Molecular dynamics (with NMR restraints)
D.A. Case
CYANA
Automated assignment and structure determination
P. Güntert
UNIO
Automation from spectral acquisition to structure
T. Herrmann
CS-ROSETTA
Structure determination from chemical shifts
O. Lange
NMR-STAR converter
Format conversion
J.L. Markley, E.L. Ulrich
ASDP
Automated NOESY cross-peak assignment
G.T. Montelione, Y.J. Huang
PSVS and PDBStat
Structure validation
G.T. Montelione, R. Tejero, Y.J. Huang
ARIA and CNS
Structure determination and refinement
M. Nilges, B. Bardiaux
XPLOR-NIH
Structure determination and refinement
C.D. Schwieters
CCPN FormatConverter
Format conversion
W.F. Vranken
CCPN
Data modeling, spectral analysis, format conversion, integration of other NMR software
G.W. Vuister, R.H. Fogh
CING
Structure validation
G.W. Vuister
CS23D
Structure determination from chemical shifts
D. Wishart
PROSESS and RESPROX
Structure validation
D. Wishart
The detailed specifications of the NEF (https://github.com/NMRExchangeFormat/NEF/) are based on the consensus that emerged during the consultations and workshops: the format accommodates a variety of restraint types and is extensible beyond the common agreed-upon elements, so that new science can be easily incorporated. The NEF format is self-contained, so that unambiguous interpretation of the data does not require any auxiliary software-specific files, and is readable by both machines and humans. In addition to the restraints data, NEF requires polymer sequence information and chemical-shift assignments, and allows inclusion of peak lists. A compliant NEF file contains all the data in a single, appropriately sectioned file, implemented with the STAR syntax[9] and controlled by a versioned dictionary of tag names. Developers can extend the standard dictionary to accommodate their own new data or experimental practices, which need not be supported by other software packages, by simply registering an individual dictionary namespace. Thus, the NEF is inherently flexible and extensible, and it allows for unlimited program-specific additional data without the need for any adaptation of the format. Importantly, it has been anticipated that such initially nonstandard additions might evolve into the general practice and be adopted by other programs. A mechanism to incorporate such developments is part of the management of the NEF specification.All authors of this Correspondence have been involved in the planning and development of the NEF, and they include representatives of all major packages for NMR structure determination, refinement and validation (Table 1). The program developers have agreed to release updated versions of their software capable of handling the NEF format by the end of September 2015. After a transition period, the wwPDB partners are expected to accept only NEF-formatted NMR data for deposition into the PDB.The efforts presented here show that the biological NMR community is ready to resolve the issues of representation and exchange of experimental NMR data. We encourage developers of current and future NMR software to support the NEF, and we invite the wider community of NMR-software developers and other stakeholders to participate in its development and maintenance.
Authors: F C Bernstein; T F Koetzle; G J Williams; E F Meyer; M D Brice; J R Rodgers; O Kennard; T Shimanouchi; M Tasumi Journal: J Mol Biol Date: 1977-05-25 Impact factor: 5.469
Authors: Gaetano T Montelione; Michael Nilges; Ad Bax; Peter Güntert; Torsten Herrmann; Jane S Richardson; Charles D Schwieters; Wim F Vranken; Geerten W Vuister; David S Wishart; Helen M Berman; Gerard J Kleywegt; John L Markley Journal: Structure Date: 2013-09-03 Impact factor: 5.006
Authors: Wim F Vranken; Wayne Boucher; Tim J Stevens; Rasmus H Fogh; Anne Pajon; Miguel Llinas; Eldon L Ulrich; John L Markley; John Ionides; Ernest D Laue Journal: Proteins Date: 2005-06-01
Authors: Jurgen F Doreleijers; Wim F Vranken; Christopher Schulte; Jundong Lin; Jonathan R Wedell; Christopher J Penkett; Geerten W Vuister; Gert Vriend; John L Markley; Eldon L Ulrich Journal: J Biomol NMR Date: 2009-10-07 Impact factor: 2.835
Authors: Eldon L Ulrich; Hideo Akutsu; Jurgen F Doreleijers; Yoko Harano; Yannis E Ioannidis; Jundong Lin; Miron Livny; Steve Mading; Dimitri Maziuk; Zachary Miller; Eiichi Nakatani; Christopher F Schulte; David E Tolmie; R Kent Wenger; Hongyang Yao; John L Markley Journal: Nucleic Acids Res Date: 2007-11-04 Impact factor: 16.971
Authors: Pedro R Romero; Naohiro Kobayashi; Jonathan R Wedell; Kumaran Baskaran; Takeshi Iwata; Masashi Yokochi; Dimitri Maziuk; Hongyang Yao; Toshimichi Fujiwara; Genji Kurusu; Eldon L Ulrich; Jeffrey C Hoch; John L Markley Journal: Methods Mol Biol Date: 2020
Authors: Antonio Rosato; Wim Vranken; Rasmus H Fogh; Timothy J Ragan; Roberto Tejero; Kari Pederson; Hsiau-Wei Lee; James H Prestegard; Adelinda Yee; Bin Wu; Alexander Lemak; Scott Houliston; Cheryl H Arrowsmith; Michael Kennedy; Thomas B Acton; Rong Xiao; Gaohua Liu; Gaetano T Montelione; Geerten W Vuister Journal: J Biomol NMR Date: 2015-06-14 Impact factor: 2.835
Authors: Swanand Gore; Eduardo Sanz García; Pieter M S Hendrickx; Aleksandras Gutmanas; John D Westbrook; Huanwang Yang; Zukang Feng; Kumaran Baskaran; John M Berrisford; Brian P Hudson; Yasuyo Ikegawa; Naohiro Kobayashi; Catherine L Lawson; Steve Mading; Lora Mak; Abhik Mukhopadhyay; Thomas J Oldfield; Ardan Patwardhan; Ezra Peisach; Gaurav Sahni; Monica R Sekharan; Sanchayita Sen; Chenghua Shao; Oliver S Smart; Eldon L Ulrich; Reiko Yamashita; Martha Quesada; Jasmine Y Young; Haruki Nakamura; John L Markley; Helen M Berman; Stephen K Burley; Sameer Velankar; Gerard J Kleywegt Journal: Structure Date: 2017-11-22 Impact factor: 5.006
Authors: Helen M Berman; Paul D Adams; Alexandre A Bonvin; Stephen K Burley; Bridget Carragher; Wah Chiu; Frank DiMaio; Thomas E Ferrin; Margaret J Gabanyi; Thomas D Goddard; Patrick R Griffin; Juergen Haas; Christian A Hanke; Jeffrey C Hoch; Gerhard Hummer; Genji Kurisu; Catherine L Lawson; Alexander Leitner; John L Markley; Jens Meiler; Gaetano T Montelione; George N Phillips; Thomas Prisner; Juri Rappsilber; David C Schriemer; Torsten Schwede; Claus A M Seidel; Timothy S Strutzenberg; Dmitri I Svergun; Emad Tajkhorshid; Jill Trewhella; Brinda Vallat; Sameer Velankar; Geerten W Vuister; Benjamin Webb; John D Westbrook; Kate L White; Andrej Sali Journal: Structure Date: 2019-11-25 Impact factor: 5.006
Authors: Simon P Skinner; Rasmus H Fogh; Wayne Boucher; Timothy J Ragan; Luca G Mureddu; Geerten W Vuister Journal: J Biomol NMR Date: 2016-09-23 Impact factor: 2.835